Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 34 | 2023 | 1020 | 9.850 |
Why?
|
| Apolipoprotein E4 | 14 | 2023 | 244 | 4.510 |
Why?
|
| Alzheimer Disease | 19 | 2023 | 2063 | 3.780 |
Why?
|
| Cognition | 27 | 2023 | 1288 | 2.750 |
Why?
|
| Aged | 70 | 2023 | 8703 | 2.710 |
Why?
|
| Cognition Disorders | 14 | 2018 | 986 | 2.670 |
Why?
|
| Stroke | 6 | 2023 | 254 | 2.580 |
Why?
|
| Female | 76 | 2023 | 14347 | 2.110 |
Why?
|
| Humans | 93 | 2023 | 25964 | 1.990 |
Why?
|
| Male | 66 | 2023 | 13980 | 1.970 |
Why?
|
| Apolipoproteins E | 8 | 2023 | 250 | 1.870 |
Why?
|
| Longitudinal Studies | 23 | 2022 | 1338 | 1.650 |
Why?
|
| Activities of Daily Living | 9 | 2018 | 522 | 1.600 |
Why?
|
| Cohort Studies | 20 | 2023 | 1815 | 1.590 |
Why?
|
| Exercise | 9 | 2023 | 451 | 1.570 |
Why?
|
| Aging | 11 | 2023 | 1535 | 1.560 |
Why?
|
| White Matter | 3 | 2022 | 141 | 1.540 |
Why?
|
| Biomarkers | 8 | 2023 | 547 | 1.510 |
Why?
|
| Population Surveillance | 3 | 2021 | 101 | 1.450 |
Why?
|
| Chicago | 20 | 2022 | 841 | 1.380 |
Why?
|
| Risk Factors | 21 | 2023 | 2240 | 1.380 |
Why?
|
| Aged, 80 and over | 30 | 2022 | 4660 | 1.300 |
Why?
|
| Vitamin E | 2 | 2023 | 26 | 1.290 |
Why?
|
| Intermediate Filaments | 4 | 2023 | 20 | 1.260 |
Why?
|
| Dementia | 8 | 2022 | 527 | 1.180 |
Why?
|
| Disease Progression | 11 | 2019 | 685 | 1.120 |
Why?
|
| Mortality | 4 | 2021 | 86 | 1.060 |
Why?
|
| tau Proteins | 3 | 2023 | 225 | 1.040 |
Why?
|
| Genotype | 6 | 2018 | 335 | 1.010 |
Why?
|
| Alleles | 8 | 2023 | 201 | 0.990 |
Why?
|
| Prospective Studies | 12 | 2023 | 1646 | 0.930 |
Why?
|
| Disability Evaluation | 4 | 2014 | 287 | 0.900 |
Why?
|
| Whole Grains | 1 | 2023 | 6 | 0.890 |
Why?
|
| Neuropathology | 3 | 2021 | 83 | 0.830 |
Why?
|
| Depression | 4 | 2014 | 407 | 0.830 |
Why?
|
| Vitamin D | 1 | 2022 | 37 | 0.800 |
Why?
|
| Incidence | 10 | 2023 | 706 | 0.800 |
Why?
|
| United States | 11 | 2023 | 1971 | 0.770 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 110 | 0.760 |
Why?
|
| Antihypertensive Agents | 2 | 2021 | 70 | 0.760 |
Why?
|
| Healthy Lifestyle | 4 | 2022 | 31 | 0.740 |
Why?
|
| Blood Pressure | 2 | 2021 | 194 | 0.730 |
Why?
|
| Neurofilament Proteins | 1 | 2020 | 7 | 0.720 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 31 | 0.720 |
Why?
|
| Membrane Proteins | 1 | 2021 | 151 | 0.700 |
Why?
|
| Geriatric Assessment | 5 | 2021 | 204 | 0.670 |
Why?
|
| Neuropsychological Tests | 11 | 2018 | 1223 | 0.610 |
Why?
|
| Diet | 4 | 2023 | 166 | 0.600 |
Why?
|
| Time Factors | 10 | 2021 | 1361 | 0.600 |
Why?
|
| Art | 1 | 2016 | 1 | 0.560 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2022 | 370 | 0.540 |
Why?
|
| Music | 1 | 2016 | 19 | 0.540 |
Why?
|
| Mental Status and Dementia Tests | 3 | 2023 | 69 | 0.540 |
Why?
|
| Diabetes Complications | 1 | 2016 | 56 | 0.530 |
Why?
|
| Models, Statistical | 2 | 2021 | 122 | 0.520 |
Why?
|
| Life Style | 5 | 2022 | 186 | 0.520 |
Why?
|
| Obesity | 6 | 2014 | 276 | 0.500 |
Why?
|
| Prevalence | 3 | 2023 | 433 | 0.500 |
Why?
|
| Mobility Limitation | 2 | 2015 | 94 | 0.490 |
Why?
|
| Cognitive Aging | 4 | 2021 | 79 | 0.480 |
Why?
|
| Body Mass Index | 6 | 2018 | 411 | 0.480 |
Why?
|
| Follow-Up Studies | 10 | 2018 | 1710 | 0.470 |
Why?
|
| Depressive Disorder | 1 | 2015 | 167 | 0.470 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 16 | 0.460 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 173 | 0.450 |
Why?
|
| Memantine | 1 | 2014 | 9 | 0.450 |
Why?
|
| Dopamine Agents | 1 | 2014 | 16 | 0.450 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2021 | 269 | 0.450 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 282 | 0.440 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 333 | 0.440 |
Why?
|
| Antioxidants | 1 | 2014 | 55 | 0.440 |
Why?
|
| Motor Activity | 2 | 2015 | 313 | 0.430 |
Why?
|
| Health Status Disparities | 1 | 2013 | 71 | 0.410 |
Why?
|
| Memory, Episodic | 3 | 2018 | 115 | 0.400 |
Why?
|
| Diagnosis | 1 | 2011 | 24 | 0.390 |
Why?
|
| Area Under Curve | 1 | 2011 | 55 | 0.390 |
Why?
|
| Medical Informatics | 1 | 2011 | 8 | 0.390 |
Why?
|
| Linear Models | 3 | 2016 | 238 | 0.370 |
Why?
|
| Refusal to Participate | 1 | 2010 | 2 | 0.360 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 457 | 0.350 |
Why?
|
| Independent Living | 3 | 2022 | 307 | 0.350 |
Why?
|
| Disabled Persons | 1 | 2012 | 124 | 0.350 |
Why?
|
| Age of Onset | 3 | 2014 | 91 | 0.310 |
Why?
|
| Middle Aged | 21 | 2019 | 8507 | 0.310 |
Why?
|
| Genetic Loci | 3 | 2018 | 54 | 0.310 |
Why?
|
| Postmenopause | 7 | 2006 | 49 | 0.290 |
Why?
|
| Memory Disorders | 2 | 2018 | 165 | 0.270 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 1140 | 0.270 |
Why?
|
| Neuroticism | 2 | 2023 | 32 | 0.250 |
Why?
|
| Hypoglycemic Agents | 2 | 2016 | 33 | 0.240 |
Why?
|
| Survivors | 3 | 2022 | 54 | 0.240 |
Why?
|
| Diet, Mediterranean | 2 | 2022 | 81 | 0.230 |
Why?
|
| Adult | 11 | 2023 | 7349 | 0.220 |
Why?
|
| Florida | 1 | 2023 | 21 | 0.220 |
Why?
|
| Sex Factors | 2 | 2022 | 442 | 0.220 |
Why?
|
| Tocopherols | 1 | 2023 | 7 | 0.210 |
Why?
|
| alpha-Tocopherol | 1 | 2023 | 10 | 0.210 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 6 | 0.210 |
Why?
|
| Flavonols | 1 | 2022 | 11 | 0.210 |
Why?
|
| Regression Analysis | 4 | 2011 | 252 | 0.210 |
Why?
|
| Vitamins | 1 | 2022 | 19 | 0.200 |
Why?
|
| Brain Infarction | 1 | 2023 | 74 | 0.200 |
Why?
|
| Dietary Supplements | 1 | 2022 | 54 | 0.200 |
Why?
|
| Life Expectancy | 1 | 2022 | 19 | 0.200 |
Why?
|
| Loneliness | 1 | 2023 | 55 | 0.200 |
Why?
|
| Age Factors | 2 | 2022 | 742 | 0.200 |
Why?
|
| Dietary Approaches To Stop Hypertension | 1 | 2022 | 28 | 0.200 |
Why?
|
| Cognitive Reserve | 1 | 2022 | 39 | 0.200 |
Why?
|
| Stress, Psychological | 2 | 2014 | 211 | 0.190 |
Why?
|
| Renin-Angiotensin System | 1 | 2021 | 5 | 0.190 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 37 | 0.190 |
Why?
|
| Cost of Illness | 1 | 2021 | 45 | 0.180 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 318 | 0.180 |
Why?
|
| Noise | 1 | 2020 | 21 | 0.180 |
Why?
|
| Early Diagnosis | 1 | 2020 | 64 | 0.180 |
Why?
|
| Mental Status Schedule | 2 | 2018 | 94 | 0.170 |
Why?
|
| Neuroimaging | 1 | 2020 | 133 | 0.170 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 159 | 0.160 |
Why?
|
| Phototherapy | 1 | 2019 | 24 | 0.160 |
Why?
|
| Confidence Intervals | 2 | 2017 | 90 | 0.160 |
Why?
|
| Residence Characteristics | 1 | 2020 | 208 | 0.160 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 11 | 0.160 |
Why?
|
| Parkinsonian Disorders | 1 | 2022 | 218 | 0.160 |
Why?
|
| Hippocampus | 1 | 2020 | 261 | 0.150 |
Why?
|
| Social Networking | 1 | 2018 | 11 | 0.150 |
Why?
|
| Healthy Aging | 1 | 2018 | 15 | 0.150 |
Why?
|
| Iodide Peroxidase | 1 | 2018 | 5 | 0.150 |
Why?
|
| Interviews as Topic | 2 | 2016 | 123 | 0.150 |
Why?
|
| Psychotropic Drugs | 1 | 2018 | 21 | 0.150 |
Why?
|
| Behavioral Symptoms | 1 | 2018 | 10 | 0.150 |
Why?
|
| Odds Ratio | 2 | 2017 | 259 | 0.150 |
Why?
|
| Nursing Homes | 1 | 2018 | 33 | 0.150 |
Why?
|
| Brain | 3 | 2022 | 1642 | 0.150 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 287 | 0.150 |
Why?
|
| Surveys and Questionnaires | 5 | 2016 | 1066 | 0.150 |
Why?
|
| Social Environment | 1 | 2018 | 78 | 0.150 |
Why?
|
| Low Back Pain | 1 | 2019 | 114 | 0.140 |
Why?
|
| Defecation | 1 | 2017 | 4 | 0.140 |
Why?
|
| Pain Management | 1 | 2019 | 137 | 0.140 |
Why?
|
| Starch | 1 | 2017 | 9 | 0.140 |
Why?
|
| Microspheres | 1 | 2017 | 22 | 0.140 |
Why?
|
| Dietary Fiber | 1 | 2017 | 20 | 0.140 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 83 | 0.140 |
Why?
|
| Prebiotics | 1 | 2017 | 21 | 0.140 |
Why?
|
| Invasive Fungal Infections | 1 | 2017 | 5 | 0.140 |
Why?
|
| Aspergillosis | 1 | 2017 | 11 | 0.140 |
Why?
|
| Mucormycosis | 1 | 2017 | 9 | 0.140 |
Why?
|
| Frozen Sections | 1 | 2017 | 13 | 0.140 |
Why?
|
| Birth Order | 1 | 2016 | 1 | 0.140 |
Why?
|
| Parity | 1 | 2016 | 2 | 0.140 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 2 | 0.140 |
Why?
|
| Reproduction | 1 | 2016 | 9 | 0.140 |
Why?
|
| Warfare | 1 | 2016 | 10 | 0.140 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 43 | 0.140 |
Why?
|
| Inflammation | 1 | 2018 | 263 | 0.140 |
Why?
|
| Terrorism | 1 | 2016 | 12 | 0.140 |
Why?
|
| Interview, Psychological | 2 | 2014 | 34 | 0.140 |
Why?
|
| Parkinson Disease | 2 | 2022 | 826 | 0.130 |
Why?
|
| Reading | 1 | 2016 | 40 | 0.130 |
Why?
|
| Clinical Competence | 2 | 2015 | 211 | 0.130 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2015 | 7 | 0.130 |
Why?
|
| Overweight | 2 | 2014 | 67 | 0.130 |
Why?
|
| Self Report | 1 | 2016 | 204 | 0.120 |
Why?
|
| Insulin | 2 | 2014 | 76 | 0.120 |
Why?
|
| Adipose Tissue | 3 | 2005 | 61 | 0.120 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 4 | 0.120 |
Why?
|
| Carbohydrates | 1 | 2015 | 6 | 0.120 |
Why?
|
| Chromatography, Gas | 1 | 2015 | 11 | 0.120 |
Why?
|
| Urinalysis | 1 | 2015 | 8 | 0.120 |
Why?
|
| Blood Glucose | 2 | 2014 | 99 | 0.120 |
Why?
|
| Models, Genetic | 1 | 2015 | 26 | 0.120 |
Why?
|
| Health Status | 2 | 2014 | 211 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 157 | 0.120 |
Why?
|
| Educational Measurement | 1 | 2015 | 53 | 0.120 |
Why?
|
| Rhinitis | 1 | 2017 | 139 | 0.120 |
Why?
|
| Sinusitis | 1 | 2017 | 156 | 0.120 |
Why?
|
| Demography | 1 | 2014 | 71 | 0.120 |
Why?
|
| Hospitalization | 2 | 2014 | 289 | 0.120 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 175 | 0.120 |
Why?
|
| Intelligence Tests | 1 | 2014 | 14 | 0.110 |
Why?
|
| Cats | 1 | 2014 | 29 | 0.110 |
Why?
|
| Hypoglycemia | 1 | 2014 | 12 | 0.110 |
Why?
|
| Models, Psychological | 1 | 2014 | 62 | 0.110 |
Why?
|
| Mindfulness | 1 | 2014 | 31 | 0.110 |
Why?
|
| Medicare | 1 | 2014 | 114 | 0.110 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 62 | 0.110 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 326 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2015 | 222 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 181 | 0.110 |
Why?
|
| Colonoscopy | 1 | 2013 | 40 | 0.110 |
Why?
|
| Adenoma | 1 | 2013 | 41 | 0.110 |
Why?
|
| Emergency Medicine | 1 | 2015 | 87 | 0.110 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 304 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2014 | 324 | 0.100 |
Why?
|
| Urban Population | 1 | 2013 | 143 | 0.100 |
Why?
|
| Social Support | 1 | 2014 | 179 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 125 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 75 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 52 | 0.100 |
Why?
|
| Breast Neoplasms | 3 | 2004 | 353 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2011 | 43 | 0.100 |
Why?
|
| ROC Curve | 1 | 2011 | 132 | 0.100 |
Why?
|
| Gait | 1 | 2015 | 408 | 0.090 |
Why?
|
| Elder Abuse | 1 | 2011 | 35 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 89 | 0.090 |
Why?
|
| Femoracetabular Impingement | 1 | 2015 | 235 | 0.090 |
Why?
|
| Frail Elderly | 1 | 2010 | 50 | 0.090 |
Why?
|
| Testosterone | 3 | 2004 | 26 | 0.090 |
Why?
|
| Self Care | 1 | 2010 | 92 | 0.080 |
Why?
|
| Quality of Life | 1 | 2014 | 609 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2010 | 193 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 485 | 0.080 |
Why?
|
| Algorithms | 1 | 2010 | 358 | 0.070 |
Why?
|
| Young Adult | 3 | 2018 | 1848 | 0.070 |
Why?
|
| Common Cold | 1 | 2006 | 6 | 0.070 |
Why?
|
| Animals | 1 | 2014 | 3386 | 0.070 |
Why?
|
| C-Reactive Protein | 2 | 2018 | 99 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2019 | 375 | 0.060 |
Why?
|
| Smoking Prevention | 1 | 2005 | 16 | 0.060 |
Why?
|
| Phenotype | 2 | 2016 | 289 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2005 | 33 | 0.060 |
Why?
|
| Feces | 2 | 2017 | 104 | 0.060 |
Why?
|
| Observer Variation | 2 | 2015 | 93 | 0.060 |
Why?
|
| Peptide Hormones | 1 | 2004 | 3 | 0.060 |
Why?
|
| Diet, Reducing | 1 | 2004 | 10 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 2005 | 47 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2005 | 92 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2017 | 398 | 0.060 |
Why?
|
| Sulfotransferases | 1 | 2004 | 5 | 0.060 |
Why?
|
| Androgens | 1 | 2004 | 7 | 0.060 |
Why?
|
| Glucuronosyltransferase | 1 | 2004 | 4 | 0.060 |
Why?
|
| Metabolic Syndrome | 1 | 2005 | 55 | 0.060 |
Why?
|
| Parents | 1 | 2005 | 104 | 0.060 |
Why?
|
| Estrogens | 1 | 2004 | 25 | 0.060 |
Why?
|
| Psychomotor Performance | 2 | 2018 | 202 | 0.060 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 6 | 0.050 |
Why?
|
| Kaempferols | 1 | 2022 | 11 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 13 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 852 | 0.050 |
Why?
|
| Eating | 1 | 2022 | 46 | 0.050 |
Why?
|
| Leisure Activities | 1 | 2022 | 13 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 99 | 0.050 |
Why?
|
| Diet Surveys | 1 | 2021 | 19 | 0.050 |
Why?
|
| Logistic Models | 2 | 2013 | 360 | 0.050 |
Why?
|
| Washington | 3 | 2006 | 5 | 0.050 |
Why?
|
| Atrophy | 1 | 2021 | 90 | 0.050 |
Why?
|
| Tremor | 1 | 2022 | 117 | 0.050 |
Why?
|
| Autopsy | 1 | 2021 | 338 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 68 | 0.040 |
Why?
|
| Smoking | 2 | 2015 | 169 | 0.040 |
Why?
|
| Child | 2 | 2018 | 1226 | 0.040 |
Why?
|
| Memory | 2 | 2011 | 300 | 0.040 |
Why?
|
| Hypertension | 1 | 2021 | 217 | 0.040 |
Why?
|
| Pain Threshold | 1 | 2019 | 17 | 0.040 |
Why?
|
| Military Personnel | 1 | 2019 | 28 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2018 | 7 | 0.040 |
Why?
|
| Neurotic Disorders | 1 | 2018 | 18 | 0.040 |
Why?
|
| Threonine | 1 | 2018 | 5 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 18 | 0.040 |
Why?
|
| Alanine | 1 | 2018 | 9 | 0.040 |
Why?
|
| Awareness | 1 | 2018 | 36 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2018 | 56 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2018 | 66 | 0.040 |
Why?
|
| Community Health Planning | 1 | 2018 | 21 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 99 | 0.040 |
Why?
|
| Veterans | 1 | 2019 | 64 | 0.040 |
Why?
|
| Chronic Pain | 1 | 2019 | 109 | 0.040 |
Why?
|
| Adolescent | 2 | 2018 | 2062 | 0.040 |
Why?
|
| Liver | 1 | 2018 | 123 | 0.040 |
Why?
|
| Fermentation | 1 | 2017 | 11 | 0.040 |
Why?
|
| Constipation | 1 | 2017 | 18 | 0.040 |
Why?
|
| Educational Status | 1 | 2018 | 281 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2017 | 34 | 0.040 |
Why?
|
| Mucor | 1 | 2017 | 5 | 0.040 |
Why?
|
| Aspergillus | 1 | 2017 | 7 | 0.040 |
Why?
|
| Nasal Surgical Procedures | 1 | 2017 | 10 | 0.040 |
Why?
|
| Maternal Age | 1 | 2016 | 11 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 51 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 8 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 43 | 0.030 |
Why?
|
| Fertility | 1 | 2016 | 17 | 0.030 |
Why?
|
| Russia | 1 | 2016 | 3 | 0.030 |
Why?
|
| Jews | 1 | 2016 | 3 | 0.030 |
Why?
|
| Israel | 1 | 2016 | 14 | 0.030 |
Why?
|
| Emigration and Immigration | 1 | 2016 | 12 | 0.030 |
Why?
|
| Nose | 1 | 2017 | 36 | 0.030 |
Why?
|
| Arabs | 1 | 2016 | 8 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 547 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 40 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 254 | 0.030 |
Why?
|
| Acute Disease | 1 | 2017 | 189 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 231 | 0.030 |
Why?
|
| Pregnancy | 1 | 2016 | 305 | 0.030 |
Why?
|
| Ankle | 1 | 2015 | 21 | 0.030 |
Why?
|
| Gallbladder | 1 | 2015 | 4 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 5 | 0.030 |
Why?
|
| Endoscopy | 1 | 2017 | 176 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 6 | 0.030 |
Why?
|
| Knee | 1 | 2015 | 44 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 21 | 0.030 |
Why?
|
| Hip | 1 | 2015 | 45 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 41 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 41 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 171 | 0.030 |
Why?
|
| Decision Making | 1 | 2017 | 222 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 2015 | 35 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2014 | 3288 | 0.030 |
Why?
|
| Kinetics | 1 | 2015 | 167 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 116 | 0.030 |
Why?
|
| China | 1 | 2014 | 50 | 0.030 |
Why?
|
| Body Weight | 2 | 2004 | 121 | 0.030 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2014 | 8 | 0.030 |
Why?
|
| Interleukins | 1 | 2014 | 25 | 0.030 |
Why?
|
| Estrone | 2 | 2004 | 8 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 57 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2014 | 38 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2004 | 14 | 0.030 |
Why?
|
| Estradiol | 2 | 2004 | 37 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 118 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 158 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 40 | 0.030 |
Why?
|
| Patient Compliance | 2 | 2005 | 145 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 610 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 639 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 132 | 0.030 |
Why?
|
| Attention | 1 | 2014 | 126 | 0.030 |
Why?
|
| Critical Illness | 1 | 2014 | 122 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 85 | 0.030 |
Why?
|
| Medical Record Linkage | 1 | 2011 | 1 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 688 | 0.020 |
Why?
|
| Length of Stay | 1 | 2014 | 301 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2014 | 279 | 0.020 |
Why?
|
| Perception | 1 | 2011 | 75 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 197 | 0.020 |
Why?
|
| Cross Infection | 1 | 2014 | 277 | 0.020 |
Why?
|
| Trail Making Test | 1 | 2010 | 4 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2010 | 10 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2010 | 16 | 0.020 |
Why?
|
| Psychometrics | 1 | 2010 | 225 | 0.020 |
Why?
|
| Caregivers | 1 | 2011 | 145 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2010 | 621 | 0.020 |
Why?
|
| Influenza Vaccines | 1 | 2006 | 9 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 929 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 22 | 0.020 |
Why?
|
| Leptin | 1 | 2005 | 19 | 0.020 |
Why?
|
| Health Education | 1 | 2005 | 44 | 0.020 |
Why?
|
| Triglycerides | 1 | 2005 | 40 | 0.020 |
Why?
|
| Ghrelin | 1 | 2004 | 2 | 0.020 |
Why?
|
| Body Size | 1 | 2004 | 10 | 0.020 |
Why?
|
| Homeostasis | 1 | 2005 | 50 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2005 | 45 | 0.010 |
Why?
|
| Body Composition | 1 | 2005 | 61 | 0.010 |
Why?
|
| Arylsulfotransferase | 1 | 2004 | 1 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2004 | 11 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2004 | 23 | 0.010 |
Why?
|
| Energy Intake | 1 | 2004 | 70 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 53 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 57 | 0.010 |
Why?
|
| New Mexico | 1 | 2003 | 3 | 0.010 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2003 | 5 | 0.010 |
Why?
|
| Anthropometry | 1 | 2003 | 34 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 78 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 313 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 713 | 0.010 |
Why?
|